Clinical trial
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
NCT00122486 · FHI 360, Other · Completed
Key facts
| NCT number | NCT00122486 |
|---|---|
| Title | Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV |
| Official title | Phase 2 Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV |
| Lead sponsor | FHI 360, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tenofovir Disoproxil Fumarate |
| Enrollment | 1,200 |
| Start date | Jul 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Jul 22, 2005 |
| Last update posted | Aug 1, 2006 |
| Countries | Cameroon, Ghana, Nigeria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: